Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Core Faculty in Innovation & Entrepreneurship
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993


Chiang, Ryan S., Ahmad Farooq, Alice Parish, Donna Niedzwiecki, Matthew R. Kappus, Yuval Patel, Rodger A. Liddle, and Andrew J. Muir. “1089 Hypophosphatemia in Patients With Alcoholic Hepatitis.” In American Journal of Gastroenterology, 114:S615–16. Ovid Technologies (Wolters Kluwer Health), 2019.

Full Text

Trauner, Michael, Aliya Gulamhusein, Bilal Hameed, Stephen Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, et al. “The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.” Hepatology 70, no. 3 (September 2019): 788–801.

Full Text

Zhang, Xiaojie, Sarah Burroughs, Ahmad Farooq, Mustafa R. Bashir, Andrew J. Muir, and Yuval A. Patel. “N-Acetylcysteine in the Management of Acute Liver Failure From Sickle Cell Hepatic Crisis.” Acg Case Rep J 6, no. 8 (August 2019): e00161.

Full Text

Di Bisceglie, Adrian M., Wendy C. King, Mauricio Lisker-Melman, Mandana Khalili, Steven H. Belle, Jordan J. Feld, Marc G. Ghany, et al. “Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.” J Viral Hepat 26, no. 7 (July 2019): 856–65.

Full Text

Hirschfield, Gideon M., Olivier Chazouillères, Joost P. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles S. Landis, Marlyn J. Mayo, et al. “Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.” J Hepatol 70, no. 3 (March 2019): 483–93.

Full Text

Muir, Andrew J., Cynthia Levy, Harry L. A. Janssen, Aldo J. Montano-Loza, Mitchell L. Shiffman, Stephen Caldwell, Velimir Luketic, et al. “Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.” Hepatology 69, no. 2 (February 2019): 684–98.

Full Text

Bailey, Donald E., Andrew J. Muir, Judith A. Adams, N Marcus Thygeson, Hants Williams, Michael P. Cary, and Ruth A. Anderson. “Clinical Encounters and Treatment Initiation for Chronic Hepatitis C Patients: Applications of Adaptive Leadership Framework for Chronic Illness.” Sage Open 9, no. 1 (January 2019).

Full Text

Younossi, Zobair, Maria Stepanova, Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu, Manal F. Abdelmalek, Anna Mae Diehl, et al. “The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.” J Hepatol 69, no. 6 (December 2018): 1365–70.

Full Text

Muir, Andrew Joseph, Jia Yao, Julius Wilder, Christina Makarushka, Kelly Keefe, James Henry Helzberg, Paolo Mannelli, et al. “The Alcohol Use Disorders Identification Test Screening in Patients with Hepatitis C.” In Hepatology, 68:908A-908A. WILEY, 2018.


Patel, Yuval, Jacqueline Henson, Julius Wilder, Matthew R. Kappus, Andrew S. Barbas, Cynthia A. Moylan, Donna Niedzwiecki, Andrew Joseph Muir, and Carl L. Berg. “The Impact of Advanced Age on Waiting List and Post-Transplantation Outcomes for NAFLD Patients.” In Hepatology, 68:683A-683A. WILEY, 2018.